Event Details
Wed, Jan 14, 2026
9am -12pm PT
San Francisco, CA
Johnson & Johnson Development Corporation (JJDC), the corporate venture capital arm of J&J, is dedicated to investing in transformative medtech startups.
JJDC portfolio companies gain access to J&J’s global expertise, scale, and longstanding commitment to advancing breakthrough science and delivering patient impact.
The JJDC investment team will be onsite at JPM 2026 and invites startup teams to meet and explore potential collaboration opportunities.
Availability is limited—don’t miss this opportunity to connect with JJDC leaders at JPM 2026.
Who Is Eligible?
The JJDC team is looking to engage with medical device companies developing technologies that align with Johnson & Johnson MedTech’s strategic focus areas, including:
- Cardiovascular
- Orthopedics
- Surgery
- Vision
Preference will be given to companies that have:
- Successfully closed a Series A funding round
- Completed first-in-human studies (for PMA pathway products) or have obtained or are within 12-months of 510(k) clearance.
Applications will be evaluated based on criteria including alignment with these focus areas and the maturity indicators listed above.
How to Apply
Applications are now open and will close on November 21, 2025.
Selected companies will be notified by mid-December following the review process.
Brought to you by:
